on behalf of the TEDDY Study Group 13 BACKGROUND/OBJECTIVES: Vitamin D and probiotics are nutrients of interest in the context of type 1 diabetes (T1D). We assessed the prevalence of and factors associated with vitamin D and probiotic supplementations among young children with genetic risk of T1D. SUBJECTS/METHODS: Use of supplements during the first 2 years of life was collected prospectively from 8674 children in The Environmental Determinants of Diabetes in the Young (TEDDY) study. RESULTS: Single and/or multivitamin/mineral (MVM) supplements were reported by 81% of the children. The majority of participants in Finland, Germany and Sweden (97-99%) and 50% in the United States received vitamin D supplements that were mostly MVMs. Probiotics use varied from 6% in the United States to 60% in Finland and was primarily from probiotics-only preparations. More than 80% of the vitamin D and probiotics supplementation was initiated during infancy, and more than half of the uses lasted longer than a year. Being the first child, longer duration of breastfeeding, born in a later year, older maternal age and higher maternal education level were associated with both vitamin D and probiotics use. Shorter gestational age and mother not smoking during pregnancy were associated with a higher likelihood of probiotics supplementation only. CONCLUSIONS: Vitamin D and probiotics supplementations are popular in children 0-2 years old and are associated with common factors. Data documented here will allow evaluation of the relationship between early childhood dietary intake and the development of islet autoimmunity and progression to T1D.
INTRODUCTION
Type 1 diabetes (T1D) is an autoimmune disease that usually manifests during childhood and is hypothesized to be triggered by both genetic and environmental factors. 1 The major genetic determinants of this disease are polymorphisms of class II human leukocyte antigen (HLA) genes encoding the HLA D-related (HLA-DR) antigens and HLA-DQ subregion (HLA-DQ). The major haplotypes of concern include DRB1*03, DQB1*0201, DRB1*04, DQB1*0302, and DRB1*0301, DQB1*0201/DRB1*04, DQB1*0302. In efforts to identify plausible environmental triggers of the disease, such as dietary exposures, the association between the risk of T1D and supplemental intake of vitamin D and/or probiotics has been studied in different populations with inconclusive findings. [2] [3] [4] [5] Vitamin D has an active role in immunological regulation and in metabolic pathways pertinent to diabetes. 6 Gut microbiota modifications via ingestion may prevent autoimmune diseases such as T1D through intestinal immune regulation, although most of the evidence so far comes from animal models. 7 However, there is limited data collected in a prospective observational manner that profile the voluntary supplementation during early childhood (0-2 years). This is a critical time period when dietary intake can make a profound and lasting impact on growth and health. Dietary supplements are concentrated sources of nutrients and can be used to achieve nutritional adequacy. National recommendations on vitamin D supplementation at this age are established in some countries with variations. In 2003, the American Academy of Pediatrics (AAP) recommended 5 μg daily supplementation to infants (0-12 months of age), children and adolescents, starting within the first 2 months after birth. 8 This recommendation was changed in 2008 to 10 μg every day beginning within days after birth and continuing throughout childhood. 8 Infants in Germany are recommended to supplement with 10 μg vitamin D every day. 9, 10 In Sweden, daily supplementation of 10 μg vitamin D is recommended for children under 2 years of age. 11 For children in the same age group in Finland, the recommendations changed from 5 to 10 μg daily depending on the use of infant formulas and milk products in 2004 12 to 10 μg daily, regardless of formula and milk consumption in 2011. 13 The research on the health benefits of probiotics has grown remarkably in recent years; however, there are no current recommendations on probiotics supplementation for the pediatric population. 14 The objective of this study is to assess the prevalence of vitamin D and probiotics supplementation in children with genetic predisposition of T1D during the first 2 years of life and to identify demographic and behavioral factors associated with this voluntary behavior.
SUBJECTS AND METHODS
The Environmental Determinants of Diabetes in the Young (TEDDY) is a prospective study that examines the roles of dietary and other environmental exposures in the development of islet autoimmunity and T1D among children carrying high-risk HLA-DR-DQ genotypes. 15 A total of 424 788 newborns were screened for high-risk HLA genotypes between September 2004 and February 2010. The screening identified 21 589 infants with eligible genotypes. Among them, 8676 infants were enrolled at six clinical centers (three in the United States: Colorado, Washington and Georgia/Florida, and three in Europe: Finland, Sweden and Germany). The participants are followed from birth until clinical diagnosis of T1D or until the child turns 15 years old. Data on their dietary supplement use was collected from parents or caretakers during the first 2 years of life. 15, 16 Detailed description about study design have been published previously. 15, 16 Separate consent letters for genetic screening and participation in prospective follow-up were obtained for all study participants from a parent or primary caregiver. The study was approved by local Ethics or Institutional Review Boards and is monitored by an External Evaluation Committee formed by the National Institutes of Health.
The caretakers of the participants reported supplement name and duration of usage on a self-administered questionnaire every 3 months between ages 0 and 2. The staff reviewed the reports shortly after they were returned in-person or by mail to the study clinics and contacted the caretakers for missing or ambiguous data. At each visit, intake dates were confirmed against those reported at previous visits. When needed, the staff would reach out to the manufacturer or distributor to verify the ingredient composition. Products that contain one or any combination of the following nutrients or constituents are recorded in the study: vitamin, mineral, fatty acid, probiotics and antioxidant compounds. 17 Fiber, herbal, homeopathic, amino acid and protein supplements were excluded. Any nutrient administered intramuscularly or subcutaneously was deemed a medication and excluded. Recorded supplements were categorized into 1 of the 37 mutually exclusive subgroups based on nutrient profile (27 single and 10 multivitamin/mineral (MVM) subgroups, see Supplementary Information). A supplement user was defined as an individual who used any supplement for at least 1 week during ages 0 and 2. The duration of supplementation was calculated based on self-reported starting and ending dates. If two or more supplements were reported in a subgroup (for example, two vitamin D products reported), the maximum overall duration was used in the analysis. This present study included data from 8674 participants, after two participants were excluded for missing Supplementary Information.
Maternal and child characteristics
Maternal age referred to the woman's age at the time of delivery, and was treated as both a continuous and a categorical variable. Maternal education was recorded on a 10-category scale designed to account for different education systems across countries. The variable was then aggregated into two categories, basic primary education (primary school through trade school) and higher education (completed trade school or higher), to achieve comparability. Prepregnancy body mass index was calculated by using self-reported weight before pregnancy (in kg) divided by the square of height (in m) and was categorized based on the World Health Organization classification. 18 Smoking and alcohol consumption during pregnancy were defined as 'yes' if reported, regardless of frequency and duration. Self-reported maternal diabetes status during pregnancy was self-reported and was grouped into 'no diabetes', 'type 1 diabetes', 'type 2 diabetes', 'gestational diabetes' and 'unknown'. Child-related variables included location of study center, year of birth, mode of delivery (vaginal vs cesarean), sex, gestational age (in weeks), birth order (first-born vs others), birth weight (in g) and whether the child has a first-degree relative (that is, mother, father and/or sibling) diagnosed with T1D. TEDDY enrollment started in late 2004 and ended in early 2010, thus the 'year of birth' variable has five values (2004-2005, 2006, 2007, 2008 and 2009-2010) . The duration of breastfeeding (in months), irrespective of the use of infant formula, was calculated based on self-reported starting and ending dates. This variable and gestational age were dichotomized based on median values in the analysis.
Statistical analysis
The 37 supplement subgroups were collapsed into vitamin D-and probiotics-containing categories. Logistic regression was used to model the odds of supplementation. The study center was always included as an independent variable in the model because preliminary examination of the data suggested that supplement use differed across centers. The remaining independent variables were chosen via a backward selection algorithm and a 0.05 level cutoff. Analyses were performed using the Statistical Analysis Software (Version 9.4; SAS Institute, Cary, NC, USA).
RESULTS
The maternal and child characteristics of the study cohort are presented in Table 1 . Overall, 81% (n = 7 008) of the participants took at least one dietary supplement for at least 1 week during the first 2 years of life. A total of 11 141 supplement products were reported. Table 2 shows the use of single and MVM supplements that contained vitamin D and probiotics.
A total of 6776 (78%) children obtained vitamin D from either single or MVM formulations, with the latter being the more popular source (4784/8096 products, 59%). Vitamin D supplementation lasted an average of 81 ± 32 weeks across all countries during the first 2 years. In comparison, 1735 (20%) participants reported taking probiotics, and the main source was single supplements that do not contain vitamin or mineral (1697/1792 products, 95%). The mean total duration of probiotics use over the first 2 years was 61 ± 36 weeks. Among children taking either type of supplements, more than half started the use during infancy. Country-specific information on the timing of supplement initiation and duration of use is shown in Table 3 .
The investigation of significant predictors of vitamin D supplement use was done solely for the US participants because the prevalence in Finland, Germany and Sweden was 97-499%. Across the three study centers in the United States, 57% of the Washington participants (787/1 377), 45% of the Colorado participants (626/1 377) and 45% of the Georgia/Florida participants (442/973) took vitamin D supplements, respectively. Higher maternal education level (P o 0.001), older maternal age at delivery (P o 0.001), being the first child (P = 0.002), longer duration of breastfeeding (P o0.001) and being born in 2009-2010 (P o 0.001) were associated with vitamin D use in the United States ( Table 4 ). The analysis of probiotic supplementation included all four countries because user proportions ranged from 6% in the United States (6% in Washington, 6% in Colorado, and 7% in Georgia/Florida) to 60% in Finland. The same factors associated with vitamin D use, plus no smoking during pregnancy (P = 0.004) and shorter gestational age (P = 0.008), were associated with higher likelihood of probiotics use ( Table 4 ). The year of birth exhibited a stronger independent association with probiotics use than with vitamin D use ( Table 4 ). The incidence of probiotics use by year of birth and by country is shown in Figure 1 .
DISCUSSION
Data from this multinational prospective cohort indicated that dietary supplement use under 2 years of age was popular among children with known genetic risk of T1D. More than half of the US participants and almost everyone in Finland, Germany and Sweden took vitamin D supplements, whereas the prevalence of probiotics use varied notably among the countries. The MVMs were the main source of vitamin D in this age group, while probiotics mainly came from single supplements.
Supplementation was initiated in the first year of life and continued for longer than 1 year by the majority of the users. A common set of demographic and behavioral factors were associated with taking vitamin D and probiotics supplements across all TEDDY countries.
Our findings can be compared to national recommendations and results from similar studies. The overwhelming majority of German children receiving supplemental vitamin D for longer than 1 year indicated a good implementation of the national recommendation. Our data echoed the BABYDIET Study in which 96.5% of children with genetic risk of T1D received vitamin D supplements during infancy. 19 The vitamin D recommendation in Sweden was also well followed. Almost all Swedish participants used vitamin D supplements within the first year of life and continued the intake for an average of 89 weeks. Seventy percent of the products reported in Sweden were a liquid preparation that contained vitamin A and D (AD-drops), which reflected the market availability during the TEDDY enrollment period (2004-2010), as the AD-drops was discontinued in 2009. The popular use of vitamin D was also noted in another study in southeastern Sweden where 99% of children were given AD-drops during infancy and 87.8% at 2.5 years of age. 20 Similarly, in northern Sweden 76% of 7-month-old infants and 74% of 10-month-old infants were given supplemental vitamin D. 21 The high prevalence and long duration of vitamin D supplementation in Finland aligned with the national recommendations. The TID Prediction and Prevention study in Finland found 91% of the children took vitamin D at 3 and 6 months of age, and 81% were still taking the vitamin at 1 year old. 22 Another Finnish study reported 50% of children took vitamin D supplements at age 2 years and the most commonly used variety was vitamin D or a combination of vitamin A and D. 23 In the United States, the proportion of supplement users (56%) was higher than the data (17%) from young children (o 2 years old) surveyed in the National Health and Nutrition Examination Survey around the same time (2007-2010 cycles). 24 Similar to the National Health and Nutrition Examination Survey results, more TEDDY participants used MVM supplements than single supplements. The higher prevalence in TEDDY might be related to the parental knowledge of the child's genetic risk and/ or the belief that supplementation may be a preventive approach as reported by 1.3% of the TEDDY families at 6 months of age and 2.2% at 15 months of age. 25 Children in National Health and Nutrition Examination Survey were more likely to receive supplements for 'tooth health and cavity prevention' than for disease treatment or prevention. 24 The research on the health benefits of probiotics has boomed in recent years. Despite the lack of national recommendations, giving probiotics to neonates is on the rise. 26 Among TEDDY participants in the United States, Germany and Sweden, o 5% born at the beginning of the study enrollment (2004) (2005) took probiotics. This number doubled in those born 5 years later (2009) (2010) in Germany and the United States. In Sweden, the use increased drastically from 0.5 to 30%. Given that TEDDY is an observational study, it is reasonable to believe the difference by birth year reflected the growing popularity of probiotics over the years. In Germany, infants were exposed to probiotics mostly through formulas that are fortified with probiotics (90.3%), 5 which might explain the relatively lower use of a separate probiotics supplement. The drastic increase in probiotics use in Sweden, particularly between 2007 and 2008, may have resulted from various marketing efforts of probiotics supplements around that time. For example, Semper Mag Droppar, a Lactobacillus reuteri Protectis supplement introduced in Sweden around 2006/2007, has been advertised for various health problems (for example, acute diarrhea, colic) to 'keep the stomach in balance. ' The favorable effect of Lactobacillus reuteri in treating infantile colic, as seen in a clinical trial in Italy, 27 might also have boosted the use of probiotics in young children. In Finland, taking probiotics during antibiotic treatment is a common practice, which might have explained the higher proportion of probiotics users seen in the 2004-2005 birth cohort. 5 The continued higher prevalence and Abbreviations: MVM, multivitamin and mineral supplement; TEDDY, The Environmental Determinants of Diabetes in the Young. a n = number of reported products; % = user percentage within a country. b MVMs are separated into vitamin D-containing products (vitamin D+) and vitamin D-free products (Vitamin D − ). c MVMs are separated into probiotics-containing products (probiotics+) and probiotics-free products (Probiotics − ). Supplement use in children aged 0-2 years longer use in that country might be attributed to the uptake of media coverage of an intervention study on probiotics and health outcomes among Finnish infants. 28 Probiotics exposure between 0 and 27 days of age from supplements and infant formulas was found to lower the risk of islet autoimmunity. 5 Such discovery may stimulate more interest in giving probiotics to children. Our analysis captured the initiation time and duration of supplement use, which is less frequently reported in the literature. Vitamin D supplementation was seen in more participants in the second year of life, but the majority of the use was initiated in the first year and more than half of the use lasted longer than a year. That further supported the notion that national recommendations on vitamin D supplementation were adhered to by many TEDDY families. Vitamin D supplements were not only taken more widely in the TEDDY European countries but also lasted longer than in the United States. One possible explanation of the shorter use in the United States was that all US participants received infant formulas fortified with vitamin D by 12 months of age, 29 which might have made the parents less likely to consider a dietary supplement. It needs to be pointed out, however, that 1 L of formula supplies 10 μg vitamin D and it is unlikely that an infant would consume that much formula per day. 8 This indicates a need to better communicate the American Academy of Pediatrics recommendations to the public to ensure all children, regardless of the consumption of formula, have adequate vitamin D intake.
The predictors of supplementation identified in this study were similar for vitamin D and probiotics, which was a good confirmation given the analysis of vitamin D included the US participants only. Some of the predictors were consistent with those reported in other studies. The effect of maternal age and parental education attainment were seen in two Finnish studies. 22, 23 The National Health and Nutrition Examination Survey 2007-2010 revealed similar associations with supplement use in children in the United States. 30 A recent analysis of the TEDDY data suggested being the first child, later birth year and mother not smoking during pregnancy were associated with probiotics exposure during infancy (0-1 year). 5 Being pregnant with the first child and higher maternal education level were also found to predict mother's supplement use during pregnancy in TEDDY. 31 It is worth noting that some of these significant factors, namely older maternal age at the child's birth, higher maternal education, no smoking during pregnancy and born in the later years of study screening period, were found to be associated with lower likelihood of withdrawal from TEDDY during the first 3 years. 32, 33 It is possible that families with these characteristics engage more actively in a variety of behaviors, such as remaining in TEDDY and using supplements. This engagement may be related to other factors, such as higher socioeconomic status, as suggested by some of the associated variables, such as older maternal age and higher education. The parental awareness of T1D risk and the decision to enroll in the study itself may have influenced the decision of giving vitamin D and probiotics supplements to their children.
To conclude, findings from this prospective study add to the knowledge of voluntary supplementation behavior in early childhood and suggested many parents of children with T1D risk paid attention to the nutrient intake recommendations. Using age-appropriate dietary supplements could be a convenient and effective way to reach the intake goal. Data from this prospective cohort will enable future evaluation of relationships between early childhood dietary intake (from foods and supplements) and the development of islet autoimmunity and progression to T1D in the at-risk children. It would also be valuable to profile the temporal trend of supplementation among the TEDDY participants as they grow older, and to evaluate whether the development of islet autoantibody, if detected during study participation, affects the supplementation behavior in these children. 
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